Abstract
Gastroesophageal reflux disease (GERD) is a chronic, progressive condition in which a dysfunction of the lower esophageal sphincter (LES) allows gastric contents to reflux into the esophagus, pharynx, respiratory tract, and mouth. The disease is typically characterized by symptoms of heartburn and regurgitation, and can progress to the complications of erosive esophagitis, Barrett’s esophagus and adenocarcinoma.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Dent J, El-Serag HB, Wallander MA, Johansson S (2005) Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 54:710–717
Shaheen NJ, Hansen RA, Morgan DR et al (2006) The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol 101:2128–2138
Thijssen AS, Broeders IA, de Wit GA, Draaisma WA (2011) Cost-effectiveness of proton pump inhibitors versus laparoscopic Nissen fundoplication for patients with gastroesophageal reflux disease: a systematic review of the literature. Surg Endosc 25:3127–3134
Dean B, Gano A, Knight K et al (2006) Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol 2:656–664
Sharma N, Agrawal A, Freeman J, Vela M, Castell D (2008) An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring. Clin Gastroenterol Hepatol 6:521–524
Lord R, DeMeester S, Peters J, Hagen J, Elyssnia D, Sheth C, DeMeester T (2009) Hiatal hernia, lower esophageal sphincter incompetence, and effectiveness of Nissen fundoplication in the spectrum of gastroesophageal reflux disease. J Gastrointest Surg 13:602–610
Vela M, Camacho-Lobato L, Srinivasan R, Tutuian R, Katz P, Castell D (2001) Simultaneous intraesophageal impedance and pH measurement of acid and non-acid gastroesophageal reflux: effect of omeprazole. Gastroenterology 120:1599–1606
Peters J, DeMeester T, Crookes P, Oberg S, deVos SM, Hagen J, Bremner C (1998) The treatment of gastroesophageal reflux disease with laparoscopic Nissen fundoplication. A prospective evaluation of 100 patients with “typical” symptoms. Ann Surg 228:40–50
Lundell L (2007) Therapy of gastroesophageal reflux: evidence-based approach to antireflux surgery. Dig Dis 25:188–196
Finks JF, Wei Y, Birkmeyer JD (2006) The rise and fall of antireflux surgery in the United States. Surg Endosc 20:1698–1701
Dallemagne B, Weerts J, Markiewicz S et al (2006) Clinical results of laparoscopic fundoplication at ten years after surgery. Surg Endosc 20:159–165
Kelly JJ, Watson D, Chin KF, Devitt PG, Game PA, Jamieson GG (2007) Laparoscopic Nissen fundoplication: clinical outcomes at 10 years. J Am Coll Surg 205:570–575
Oelschlager BK, Quiroga E, Parra JD, Cahill M, Polissar N, Pellegrini C (2007) Long-term outcomes after laparoscopic antireflux surgery. Am J Gastroenterol 102:1–8
Morgenthal CB, Shane MD, Stival A et al (2007) The durability of laparoscopic Nissen fundoplication: 11-year outcome. J Gastrointest Surg 11:693–700
Vakil N, Shaw M, Kirby R (2003) Clinical effectiveness of laparoscopic fundoplication in a US community. Am J Med 114:1–5
Hunter J, Smith C, Branum G et al (1999) Laparoscopic fundoplication failures: patterns of failure and response to fundoplication revision. Ann Surg 230:595–606
Smith CD, McClusky DA, Rajad MA et al (2005) When fundoplication fails- redo? Ann Surg 241:861–871
Ganz R, Gostout C, Grudem J et al (2008) Use of a magnetic sphincter for the treatment of GERD: a feasibility study. Gastrointest Endosc 67:287–294
Bonavina L, Saino G, Bona D et al (2008) Magnetic augmentation of the lower esophageal sphincter: results of a feasibility clinical trial. J Gastrointest Surg 12:2133–2140
Bonavina L, DeMeester TR, Fockens P et al (2010) Laparoscopic sphincter augmentation device eliminates reflux symptoms and normalizes esophageal acid exposure. Ann Surg 252:857–862
Lipham JC, DeMeester TR, Ganz RA, et al (2012) Apr. 27 PMID: 22538694. The Linx reflux management system: confirmed safety and efficacy now at four years. Surg Endosc
Migliore A, Corio M, Paone S, Jefferson T, Cerbo M (2011) Implantable device for patients with gastro-oesophageal reflux disease. Agenas, Agenzia nazionale per i servizi sanitari regionali. Horizon Scanning report no. 9. Agenas, Rome, April 2011. www.agenas.it
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Italia
About this chapter
Cite this chapter
Bonavina, L., Saino, G., Bona, D., DeMeester, T.R. (2012). Magnetic Augmentation of the Lower Esophageal Sphincter: Changing the Treatment Paradigm in Patients with Gastroesophageal Reflux Disease. In: Bonavina, L. (eds) Innovation in Esophageal Surgery. Springer, Milano. https://doi.org/10.1007/978-88-470-2469-4_3
Download citation
DOI: https://doi.org/10.1007/978-88-470-2469-4_3
Published:
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2468-7
Online ISBN: 978-88-470-2469-4
eBook Packages: MedicineMedicine (R0)